Clinical Trials Browser

OTHER × Meningeal Carcinomatosis × Busulfan × Clear all

NCT00003462 2013-02-20

Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors

Phase 1 Completed

Central Nervous System Neoplasms, Meningeal Carcinomatosis